Diagnostics in Diverticulitis (DIDit)
1 other identifier
interventional
149
1 country
1
Brief Summary
This study focuses on if low dose CT without intravenous contrast has a high enough specificity and sensitivity for acute diverticulitis that it can be used as the primary diagnostic method instead of a full dose CT with intravenous contrast which is the standard method in Sweden.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 26, 2016
CompletedStudy Start
First participant enrolled
January 19, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2018
CompletedFirst Posted
Study publicly available on registry
February 22, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2018
CompletedMay 3, 2018
May 1, 2018
12 months
December 26, 2016
May 2, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Presence of diverticulitis on low dose CT and/or full dose CT
Colonic wall thickening \>5mm, pericolic fat stranding and diverticula on CT
Baseline
Study Arms (1)
participants
EXPERIMENTALAll participants will be examined with both CT techniques. First a low dose CT without intravenous contrast followed by the standard method, a full dose CT with intravenous contrast
Interventions
participants will receive an extra radiation dosage of about 3 milli Sievert (mSv) depending on patients height and weight. This is the radiation amount from the low dose CT protocol without intravenous contrast.
Eligibility Criteria
You may qualify if:
- Over the age of 50
- Clinically suspected acute diverticulitis
- Low abdominal pain
- WBC over 10 x 109/L or raised C-reactive protein levels 25 mg/L
You may not qualify if:
- Pregnancy
- Previous allergy to intravenous contrast
- Renal failure or other reasons that the patient cannot undergo CT with iv contrast
- Unable to give informed consent
- Dementia
- Language barrier
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Uppsala Universitylead
- Centrallasarettet Västeråscollaborator
- Mora Hospital, Landstinget Dalarnacollaborator
Study Sites (1)
Region Vastmanland Hospital
Västerås, Västmanland County, 721 89, Sweden
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Kenneth Smedh, Professor
Center for Clinical Reasearch Vasteras
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Consulting radiologist
Study Record Dates
First Submitted
December 26, 2016
First Posted
February 22, 2018
Study Start
January 19, 2017
Primary Completion
January 1, 2018
Study Completion
March 1, 2018
Last Updated
May 3, 2018
Record last verified: 2018-05
Data Sharing
- IPD Sharing
- Will not share